Comparison

Finerenone European Partner

Manufacturer TargetMol
Category
Type Molecules
Specific against other
Amount 25mg
Item no. TMO-T21395-25mg
CASRN 1050477-31-0
eClass 6.1 32169090
eClass 9.0 32169090
Available
Short Description
Finerenone is a third-generation, selective, and orally available nonsteroidal mineralocorticoid receptor (MR) antagonist with IC50 of 18 nM for the treatment of chronic heart failure. Finerenone displays excellent selectivity versus glucocorticoid receptor (GR), androgen receptor (AR), and progesterone receptor (>500-fold).
Shipping
cool pack
Storage
-20°
Target names or alias
BAY 94-8862 , BAY-94-8862 , BAY948862 , BAY94-8862 , BAY-948862 , BAY 948862
Molecular Weight
378, 43
Pathway
Endocrinology/Hormones
Target
Glucocorticoid Receptor

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Amount: 25mg
Available: In stock
available

Delivery expected until 5/9/2024 

Compare

Add to wishlist

Get an offer

Request delivery time

Ask a technical question

Submit a bulk request

Questions about this Product?
 
Close